loader
Please Wait
Applying Filters...

Seqens Seqens

X

Looking for MolPort-000-872-072? Find Direct Compression used in MolPort-000-872-072 to address drug delivery challenges on PharmaCompass.

Filters Filter
Cross PopUp
FILTER :

filter

01 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd (1)

02 BASF (8)

03 Ulanqab Kema New Material (3)

filter

01 Capsule (2)

02 Granule / Pellet (3)

03 Tablet (5)

04 Topical Film (1)

05 Transdermal Patch (1)

filter

01 China (4)

02 Germany (8)

Close
4

Applications:

For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.

Ingredient(s): Hydrated Silica, Lauryl Sulfate, Polyvinyl Acetate, Povidone

Dosage Form: Capsule, Tablet, Topical Film, Transdermal Patch

Category: Controlled & Modified Release, Direct Compression, Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JP-JPE: 80 % Polyvinyl acetate and 19 % povidone, 0.8 % lauryl sulfate & 0.2 % silica (4:1)

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Ready-to-use direct compression solution for tablets.

Ingredient(s): Crospovidone, Lactose, Povidone

Dosage Form: Granule / Pellet, Tablet

Category: Direct Compression, Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph.Eur., USP/NF and JP

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Applications:

Ready-to-use direct compression solution for lozenges, chewables and effervescent tablets.

Ingredient(s): Lactose, Povidone

Dosage Form: Granule / Pellet, Tablet

Category: Direct Compression, Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP/NF and J.P

Technical Specifications: Not Available

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY